JJ

Jonathan Jon Pilcher

Neuren Pharmaceuticals Limited | Chief Executive Officer, Managing Director
Mr Pilcher has played a central role in all aspects of the company's R&D, commercial and corporate activities. He formerly spent seven years in a series of executive positions in the R&D and corporate functions of international pharmaceutical groups Medeva and Celltech, which are now part of UCB.

Company and Roles

Company
Title
Tenure
Since
NEU
Neuren Pharmaceuticals Limited
  • Chief Executive Officer
  • Managing Director
12yrs, 9mthAug 2013

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NEU
Neuren Pharmaceuticals Limited
16/03/261,500,000N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NEU
Neuren Pharmaceuticals Limited
08/09/25
Sell
398,207$20.000$7,964,140On-market trade
NEU
Neuren Pharmaceuticals Limited
22/07/25
Buy
1,500,000$1.840$2,760,000Conversion of securities
NEU
Neuren Pharmaceuticals Limited
22/07/25
Exercise
1,500,000$1.840$2,760,000Conversion of securities
NEU
Neuren Pharmaceuticals Limited
08/10/21
Buy
7,317$2.050$15,000Participation in share purchase plan
NEU
Neuren Pharmaceuticals Limited
15/06/21
Buy
19,039$1.313$25,000On-market trade